Table 1.

Association of FSAP Marburg I with VTE




No.

Carriers of FSAP Marburg I, no. (%)

Comparison vs controls I, odds ratio (95% CI)

Comparison vs controls II, odds ratio (95% CI)
Idiopathic VTE   103   12 (11.7)   5.5 (1.9,16.0)*  2.7 (1.2,6.1) 
Secondary VTE   110   5 (4.5)   2.0 (0.56,7.0)*  0.99 (0.35,2.8)  
VTE   213   17 (8.0)   3.6 (1.3,10.0)*  1.8 (0.88,3.7)  
Controls I   213   5 (2.3)   NA   NA  
Controls II
 
327
 
15 (4.6)
 
NA
 
NA
 



No.

Carriers of FSAP Marburg I, no. (%)

Comparison vs controls I, odds ratio (95% CI)

Comparison vs controls II, odds ratio (95% CI)
Idiopathic VTE   103   12 (11.7)   5.5 (1.9,16.0)*  2.7 (1.2,6.1) 
Secondary VTE   110   5 (4.5)   2.0 (0.56,7.0)*  0.99 (0.35,2.8)  
VTE   213   17 (8.0)   3.6 (1.3,10.0)*  1.8 (0.88,3.7)  
Controls I   213   5 (2.3)   NA   NA  
Controls II
 
327
 
15 (4.6)
 
NA
 
NA
 

Controls I indicates healthy blood donors; controls II, non-VTE patients; and NA, not applicable.

*

The data presented here (univariate analyses) differ slightly from those of our initial report (logistic regression analyses; independent variables: factor V Leiden, prothrombin 20210G→A, and FSAP Marburg I).

P = .001 (Fisher exact test).

P < .05 (Fisher exact test).

or Create an Account

Close Modal
Close Modal